Imprese · 25/07/20181 min di lettura
Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing competition and innovation in the biological products marketplace, including by facilitating greater availability of biosimilar and interchangeable products.